Mirabito Expands Footprint with Acquisition of 9 Quicklees Convenience Stores Nvidia Earnings in Focus Jensen Huangs Commentary on Trump and China Chip Restrictions After Xi Summit Trump Postpones AI Executive Order Cites Concerns Over Potential Blocker Texas Files Lawsuit Against Meta and WhatsApp Over Encryption Privacy Claims Barclays Reports 18 Profit Increase Upgrades FullYear Income Guidance IBM Surges on 2 Billion Federal Quantum Computing Boost Adds 27 Billion in Market Value Surrozen Q1 2026 Earnings Staggering EPS Miss of 1165 Versus Estimate Stock Declines 266 Atossa Therapeutics Q1 2026 Earnings Narrowed Loss Beats Estimates as Clinical Pipeline Advances Seaboard Corporation SEB Q1 2026 Earnings Strong EPS Performance Amid Mixed Market Signals CBOE Q1 2026 Earnings EPS Surges Past Estimates on Strong Trading Activity THFF Q1 2026 Earnings Shares Slip Despite Narrow EPS Beat Kinsale Capital Group Q1 2026 Earnings EPS Surpasses Estimates by 672 Tempest Therapeutics TPST Edges Higher as Biotech Sector Shows Renewed Interest Neptune Insurance Holdings Gains 38 Key Resistance Levels in Focus Franklin Resources BEN Holds Steady Near Key Support as Asset Manager Faces Headwinds Wolverine World Wide WWW Edges Higher as Stock Tests Key Resistance Zone Blackrock MuniYield New York Quality Fund MYN Edges Higher Approaching 10 Resistance Minerva Neurosciences Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Faces Challenges VTEX Q1 2026 Earnings EPS Miss Sends Shares Lower Amid Revenue Uncertainty EDUC Q1 2026 Earnings Net Loss Reported as Company Navigates Transition CRDO Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge Ark Restaurants Q4 2025 Earnings Net Loss Reported No Revenue Detail Disclosed Tompkins Financial Corporation TMP Q1 2026 Earnings EPS Beat of 277 Amid Steady Operating Performance NFL Seeks Ban on Certain Sports Prediction Contracts Including GameSpecific Bets and Injury Markets EBAY Q1 2026 Earnings EPS Beat Fails to Lift Stock as Market Digests Mixed Signals Cellectar Biosciences CLRB Posts Modest Gains as Shares Consolidate Near Resistance